Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.

Communications medicine·2026

Same author

Bringing the apheresis world together again.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2022

Same author

Early COVID-19 pandemic modeling: Three compartmental model case studies from Texas, USA.

Computing in science & engineering·2022

Same author

A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021

Same author

Editor's note.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2021

Same author

<i>trips4health</i>: Protocol of a single-blinded randomised controlled trial incentivising adults to use public transport for physical activity gain.

Contemporary clinical trials communications·2020

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

Autologous blood programs: what is happening?

G Rock¹, R Berger, D Filion

¹Department of Pathology, The University of Ottawa, Canadian Apheresis Group, Suite 199, 435 St. Laurent Boulevard, Ottawa, Ontario, Canada K1K 2Z8. cag@ca.inter.net

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis

|November 11, 2008

Summary

Autologous blood programs in Ontario show significant variability in service provision and integration with Canadian Blood Services (CBS). This contrasts with standardized whole blood and apheresis collections, highlighting a need for greater consistency in autologous blood services.

More Related Videos

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Related Experiment Videos

Last Updated: Jun 28, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Area of Science:

Transfusion Medicine
Healthcare Management

Background:

Preoperative autologous blood collection has gained prominence, particularly post-AIDS epidemic.
Despite increased application, autologous blood programs face both praise and criticism, with limited data on their actual implementation.

Purpose of the Study:

To assess the demographics, logistics, and funding of autologous blood programs in Ontario's largest hospitals.
To identify variations in autologous blood service availability and operation across the province.

Main Methods:

A survey was distributed to 155 large hospitals in Ontario.
78 hospitals responded, providing data on their autologous blood program access, structure, and funding.

Main Results:

77 of 78 responding hospitals had access to an autologous program.
26 hospitals had in-house programs, while 62 utilized Canadian Blood Services (CBS).
15 hospitals lacked any autologous program access; some programs were funded by patient fees.

Conclusions:

Autologous blood programs in Ontario exhibit considerable variability, with some regions lacking services while others have active programs.
This variability contrasts sharply with the standardized approach to whole blood and apheresis collections managed by CBS.
There is a notable lack of standardization in autologous blood collection services across Canadian provinces.